Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v1-EN
Language French English
Date Updated 2019-02-06 2019-02-01
Drug Identification Number 02231129 02231129
Brand name SEREVENT DISKUS (50MCG/DOSE) SEREVENT DISKUS (50MCG/DOSE)
Common or Proper name salmeterol xinafoate dry powder for inhalation salmeterol xinafoate dry powder for inhalation
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients SALMETEROL SALMETEROL
Strength(s) 50MCG 50MCG
Dosage form(s) POWDER POWDER
Route of administration INHALATION INHALATION
Packaging size 1x60 1x60
ATC code R03AC R03AC
ATC description ADRENERGICS, INHALANTS ADRENERGICS, INHALANTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-02-05
Actual start date 2019-02-06
Estimated end date 2019-02-15 2019-02-15
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments